investor.dyax.com investor.dyax.com

investor.dyax.com

Dyax Corp. - Investor Relations

Advancing Novel Biotherapeutics Since 1995. Product and Development Portfolio. Opportunities for growth stem from our established success and valued collaborations. Gustav A. Christensen. Burt Adelman M.D. Financial and SEC Reports. Dyax is a biopharmaceutical company focused on developing and commercializing products for unmet medical needs. We currently market a product for the treatment of acute attacks of hereditary angioedema (HAE), a rare genetic disease (to learn more, click here. Aug 6, 2015.

http://investor.dyax.com/

WEBSITE DETAILS
SEO
PAGES
SIMILAR SITES

TRAFFIC RANK FOR INVESTOR.DYAX.COM

TODAY'S RATING

>1,000,000

TRAFFIC RANK - AVERAGE PER MONTH

BEST MONTH

October

AVERAGE PER DAY Of THE WEEK

HIGHEST TRAFFIC ON

Saturday

TRAFFIC BY CITY

CUSTOMER REVIEWS

Average Rating: 3.5 out of 5 with 4 reviews
5 star
2
4 star
0
3 star
1
2 star
0
1 star
1

Hey there! Start your review of investor.dyax.com

AVERAGE USER RATING

Write a Review

WEBSITE PREVIEW

Desktop Preview Tablet Preview Mobile Preview

LOAD TIME

CONTACTS AT INVESTOR.DYAX.COM

Login

TO VIEW CONTACTS

Remove Contacts

FOR PRIVACY ISSUES

CONTENT

SCORE

6.2

PAGE TITLE
Dyax Corp. - Investor Relations | investor.dyax.com Reviews
<META>
DESCRIPTION
Advancing Novel Biotherapeutics Since 1995. Product and Development Portfolio. Opportunities for growth stem from our established success and valued collaborations. Gustav A. Christensen. Burt Adelman M.D. Financial and SEC Reports. Dyax is a biopharmaceutical company focused on developing and commercializing products for unmet medical needs. We currently market a product for the treatment of acute attacks of hereditary angioedema (HAE), a rare genetic disease (to learn more, click here. Aug 6, 2015.
<META>
KEYWORDS
1 dyax
2 about dyax
3 our technology
4 investor information
5 corporate governance
6 board of directors
7 committee composition
8 management
9 george migausky
10 andrew ashe
CONTENT
Page content here
KEYWORDS ON
PAGE
dyax,about dyax,our technology,investor information,corporate governance,board of directors,committee composition,management,george migausky,andrew ashe,todd bazemore,investor events,press releases,stock information,stock chart,historic price lookup,price
SERVER
Microsoft-IIS/8.5
CONTENT-TYPE
utf-8
GOOGLE PREVIEW

Dyax Corp. - Investor Relations | investor.dyax.com Reviews

https://investor.dyax.com

Advancing Novel Biotherapeutics Since 1995. Product and Development Portfolio. Opportunities for growth stem from our established success and valued collaborations. Gustav A. Christensen. Burt Adelman M.D. Financial and SEC Reports. Dyax is a biopharmaceutical company focused on developing and commercializing products for unmet medical needs. We currently market a product for the treatment of acute attacks of hereditary angioedema (HAE), a rare genetic disease (to learn more, click here. Aug 6, 2015.

OTHER SITES

investor.dsv.com investor.dsv.com

DSV A/S - Investor Relations

Select your DSV site. Global Website (dsv.com). Middle East and Africa. Democratic Republic of Congo. Financial reports and webcasts. Recommendations on corporate governance. Analyst coverage and consensus. Information på dansk. CONCLUSION OF SHARE BUYBACK PROGRAMME IN DSV A/S. DSV, 687 - Share buyback in DSV A/S. DSV, 686 - Share buyback in DSV A/S. DSV, 685 - Annual General meeting in DSV A/S 8 March 2018. Company Announcement No. 685 The annual general mee. Selskabsmeddelelse nr. 688 30. oktob...Selsk...

investor.dts.com investor.dts.com

Investor Relations

MOVIES, MUSIC and GAMES. Streaming and Media Formats. Neo:X and Neural Surround. DTS Reports Q1 2015 Financial Results. Q1 2015 Investor Fact Sheet. Q1 2015 Investor Presentation. Q1 2015 Financial Model. 2015 Non-GAAP Financial Targets. DTS to Report Second Quarter Fiscal 2015 Financial Results. DTS Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4). Upcoming Events and Presentations. 08/10/2015 at 1:30 PM PT. Q2 2015 DTS, Inc. Earnings Conference Call. Movies, Music and Games.

investor.dukerealty.com investor.dukerealty.com

Overview - Investor Relations - Duke Realty

Duke Realty Investor Relations. Corporate Social Responsibility Governance. Code of Conduct (PDF). Duke Realty Investor Relations. Q2 2015 Duke Realty Earnings Conference Call. 160;at 3:00 pm ET. Q2 2015 Duke Realty Earnings Conference Call. Thursday, July 30, 2015 . 3:00 pm ET  . Click here for webcast. Duke Realty at 2015 NAREIT REITWeek Conference. 160;at 11:45 am ET. Duke Realty at 2015 NAREIT REITWeek Conference. Tuesday, June 9, 2015 . 11:45 am ET  . Click here for webcast. INDIANAPOLIS, IN - (Mark...

investor.dunkinbrands.com investor.dunkinbrands.com

Investor Relations | Dunkin Brands, Inc.

Skip to main navigation. Sign up for Email Alerts. Annual Reports and Proxies. Corporate Social Responsibility Reports. How to Get Involved. Feb 06, 2018. Nov 08, 2017. Mar 27, 2017. Mar 27, 2017. Feb 22, 2017. Mar 15, 2018. Dunkin' Brands Announces Three New Executive Promotions. Feb 08, 2018. Dunkin' Brands Presents Three-Year Plan Fueled by the Dunkin' Donuts U.S. Blueprint for Growth at its 2018 Investor and Analyst Day. Feb 06, 2018. Dunkin' Brands 2018 Investor and Analyst Day.

investor.dvcr.com investor.dvcr.com

Investor Info

Aug 14, 2015 4:00 PM ET. Welcome to Diversicare Healthcare Services updated website. In an effort to provide you with investor and operations information about our company, we have created a more user friendly site. Thank you for your interest in Diversicare Healthcare Services, Inc. View all ». Aug 6, 2015. Diversicare Announces 2015 Second Quarter Results. Jul 22, 2015. Diversicare to Announce Second Quarter 2015 Financial Results on Thursday, August 6, 2015. View all ». Aug 7, 2015.

investor.dyax.com investor.dyax.com

Dyax Corp. - Investor Relations

Advancing Novel Biotherapeutics Since 1995. Product and Development Portfolio. Opportunities for growth stem from our established success and valued collaborations. Gustav A. Christensen. Burt Adelman M.D. Financial and SEC Reports. Dyax is a biopharmaceutical company focused on developing and commercializing products for unmet medical needs. We currently market a product for the treatment of acute attacks of hereditary angioedema (HAE), a rare genetic disease (to learn more, click here. Aug 6, 2015.

investor.dynamic.ca investor.dynamic.ca

Login | Dynamic Funds

Log in to access your account. Remember my User name on this computer. Forgot User Name or Password? If you have questions about accessing the site, please call the Customer Relations Centre for assistance. Toll Free (866) 212-9295. What is an Access ID? Your Access ID is a computer-generated registration number you receive with your account statement. It provides secure personal access to the Dynamic Investor Portal. If you don't have one, find out how to get an Access ID. Contact us at (866) 212-9295.

investor.e-ttmc.com.tw investor.e-ttmc.com.tw

鑫科材料科技股份有限公司

矽晶型太陽能電池用導電膠, 顯示器用濺鍍靶材, 光碟片(光儲存記錄媒體)用濺鍍靶材, 薄膜太陽能電池用濺鍍靶材, 鑫科材料科技股份有限公司 - 聯絡我們. 電話: 886-7-6955125 傳真: 886-7-6955205 E-mail: service@e-ttmc.com.tw.

investor.ea.com investor.ea.com

Electronic Arts Inc. - Investor Relations

IPhone and iPod touch. Q3 FY18 Prepared Remarks. Q3 FY18 Earnings Release. Q3 FY18 Earnings Slides. Q3 FY18 Financial Model. Q3 FY18 Investor FAQs on 606 FAQs. Q2 FY18 Prepared Remarks. Q2 FY18 Earnings Release. Q2 FY18 Earnings Slides. Q2 FY18 Financial Model. May 17, 2016 at 8:00 AM PT. CEO Presentation by Andrew Wilson. CFO Presentation by Blake Jorgensen. IR Introduction by Chris Evenden. Studios Presentation by Patrick Soderlund. Competitive Gaming Division by Peter Moore. Jul 19, 2016 at 2:00 PM PT.

investor.eastwater.com investor.eastwater.com

Investor Relation | Eastwater Group

Water reserves in reservoirs. Quality and Environmental Policy. Life - Long Education. Process of Water Distribution. Operation and Maintenance Management. Welcome to Investor Relations. Highlights of the year. Water Sale Volume Report. Dividend Policy and Payment. Sustainable growth of broader vision". Management Discussion and Analysis Quarter 3 Ending 30-Sep-2016. Reviewed Quarter 3 and Consolidated F/S (F45-3). Keep yourself up to date with all the latest announcements from the company.

investor.eastwestbank.com investor.eastwestbank.com

Corporate Profile | East West Bank

Annual Reports and Proxy. Share Price and Tools. Historical Price Look Up. As of August 7, 2015 -. Minimum 20 minute delay. Welcome to Investor Relations. East West Bancorp Reports Net Income for Second Quarter 2015 of $98.7 Million, Up 17% from Prior Year, and Diluted Earnings Per Share of $0.68, Up 15% from Prior Year. East West Bancorp Announces Dates for Second Quarter 2015 Financial Results. East West Bancorp Announces Dates for First Quarter 2015 Financial Results. East West Bancorp, Inc. To reques...